Company: STAA
Filing Date: 2025-10-20
Form Type: DFAN14A
Source: 0001213900-25-100410
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-10-20
Form: DFAN14A
Chunk 1
---
 the “Special Meeting”). The Participants have filed a definitive proxy statement on Schedule 14A (the “Definitive
Proxy Statement”) and accompanying GREEN Proxy Card to be used in connection with any such solicitation of proxies
from the Company’s stockholders for the Special Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE FILED OR WILL FILE WITH THE U.S. SECURTIES AND EXCHANGE COMMISSION (THE “SEC”) BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND additional information relating to the Participants and their direct or indirect interests, by security holdings or otherwise. The Definitive Proxy Statement and accompanying GREEN Proxy
Card have been furnished to some or all of the Company’s stockholders and will be, along with other relevant documents, available
at no charge on the SEC’s website at https://www.sec.gov/.

Information about the Participants and a description
of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants
with the SEC on September 26, 2025 and is available here.

Exhibit 1

<div align='center'>Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon

Leading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwood’s Concerns over Deeply Deficient Sale Process, Timing, and Price

Shareholders Representing More than 34% of STAAR’s Outstanding Common Shares Have Publicly Opposed the Transaction

Broadwood Urges All Shareholders to Vote “ AGAINST” the Proposed Acquisition</div>

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates
(“Broadwood” or “we”) today commented on the increasing public opposition to the proposed acquisition of STAAR
Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC). Broadwood
continues to urge its fellow shareholders to vote on the GREEN Proxy Card “AGAINST”
the transaction at a virtual Special Meeting of Stockholders to be held on October 23, 2025, at